Reducing seven risk factors for heart disease and having higher Life's Simple 7 scores may help decrease biomarkers for ...

Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

Scientists at St. Jude Children’s Research Hospital have used positron emission tomography (PET) with edaravone, a drug used ...

It's a neurological disorder in which the body's immune system attacks the peripheral nervous system. This is the part of the nervous system outside the brain and spinal cord. The onset of GBS can be ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

There is a fascinating field of study called Psychoneuroimmunology (PNI), which investigates the connections between the ...

PET imaging is improved by employing edaravone to track oxidative stress, allowing for earlier detection of neurodegenerative ...

Virtual Fireside Chat 1x1 Meetings: Please contact your Roth representative. A webcast of the presentation will be available on the “ Events ” section of the Clene website. Alternatively, one can ...